Member Info for aj242

Several years later and I still see the same names on this forum talking about this company haha accept your fate, its dead

Mental that I still see the same names from 2020-2021 hoping this company will do something lol

double digits by the end of the month

lets be honest, this should be in double figures with the contracts they now have.

Time to take the L here lads, its a shame

surprised this hasn't moved a lot more today. Expect this to be double digits halfway through June

no there isn't

Its not obvious with hindsight. It was clear as day. You were blind. And now you complain that I am being negative when if you actually took time to read and understand what I was saying, you probably won't be in red.

Guessed? Was it not quite obvious? I invested here 2 years ago and yes, I did make a slight loss overall. The only reason my tune changed because it was so obvious to see that this is not going anywhere anytime soon. Yes we know the drug works in a subset of patients, but to prove this on a larger scale, we need a new platform study which will take years. Regarding activ-2, its very obvious that this wasn't going to proceed given the changing landscape of the virus. I do think if you average is below 30p and you are willing to wait 2 years, then this will most certainly come good. But I am sick of the vermin on this board ramping this share convincing others who are more naive to invest into something that isn't going "back to 1.50" anytime soon.

The rampers got excited last week with the rise following the update. I told you activ-2 wasn't going to go ahead for many of the same reasons detailed in the RNS. You laughed and told me leave the board.

Remove the rose tinted glasses fgs!!!!

I can't beleive Dan the man is back again!

the market is irrelevant in its first hour. THis will be red at close.

We are in March....

its confirmed it has been paused, there is still a huge chance that the whole trial will be cancelled. Even if this trial continues, we are now looking at 18 months until data. We never had doubts that SNG001 would work against omicron. Be OBJECTIVE

you do realise a platform study hasn't been designed yet let alone begun....we are talking 3 years at least.

mcadder you are honestly a meme on this board.

Be objective about this RNS. Remove the rose tinted glasses. Activ-2 is on pause, which is horrible news as that was the "near term" (12 month) SP accelerator. Yes we are potent against omicron, we never thought we weren't. Yes there were some trends in sprinter which needs a PLATFORM study. Nothing is going to happen for at least 18 months now.

no

a 25% tree shake to fill an order for a company with a failed drug. Ok mate

mcadder said its your"last chance to buy under 25p" at 8:30 this morning, he will now say its your last change to buy under 20p soon.